| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate |
2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea0d7d67f21cb2f6a05fbd57927da917
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_449d20777ff4be7452352519b710d9cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29f17772671534ae25394d191495a51c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6ebf63a5e841744258f7ca42e5daa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47c3ab60d15c88cd8c308fa0801ba546
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f696ee83f0b555f30b847558738b1a20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_657a804a3d76859dbe113c774d5b55eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03986bbb68bf7030173a34bc1da4957a |
| publicationDate |
2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190138244-A |
| titleOfInvention |
A composition for preventing or treating of graft versus host disease comprising conditioned medium of tonsil-derived mesenchymal stem cell |
| abstract |
The present invention provides a composition for preventing, ameliorating or treating graft-versus-host disease, comprising an adjusting medium of tonsil-derived mesenchymal stem cells as an active ingredient. The composition according to the present invention has excellent effects in the prevention and treatment of graft-versus-host disease by inhibiting the migration and immune response of transplanted lymphocytes, including various immune modulators. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210095575-A |
| priorityDate |
2018-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |